ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
Adam Feuerstein/STAT
By STAT StaffMay 30, 2026
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.
A huge thanks to everyone who attended the jam-packed STAT @ ASCO event last night. The bao buns were incredible. IYKYK.
Don’t forget to sign up for our ASCO virtual recap on Wednesday.
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting.…
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck,…
Mystery cloaks an ASCO plenary lung cancer survival result.
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Placement on the plenary session of the upcoming ASCO 2026 annual meeting has significantly elevated enthusiasm around Akeso’s…
